Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 24, 2000

View Archived Issues

Neurobiological Technologies and UC, Berkeley sign option agreement for CRF analogues

Designer transcription factor used to activate erythropoietin gene

Medarex and Athersys form therapeutic antibody partnership

Bayer and PPL Therapeutics to jointly develop aerosol AAT formulation

Schering-Plough receives extended marketing exclusivity, submits sNDAs for loratadine

Antex Biologics signs CRADA with U.S. Navy for Campylobacter vaccine

GlycoDesign and Leo Denmark form joint venture to develop cardiovascular drugs

Altea Genomics and Elan to jointly develop DNA vaccines

Novel lymphoma marker discovered using gene expression arrays

Ultrasound contrast agent deemed approvable by the FDA

Ilex and Millennium respond to FDA letter on Campath

Cel-Sci to commence phase II Multikine study in Czech Republic

FDA approves Azulfidine EN-tabs as treatment of juvenile RA

Antigenics to acquire Aquila Biopharmaceuticals

Serotonin antagonist improves drinking behavior in early-onset alcoholism

Cancer researchers reveal extended activity of tyrosine kinase inhibitor

Parke-Davis reports SAR of nonpeptide IL-8 receptor antagonists

Orally active nonpeptide NK1 antagonist selected by Fujisawa for clinical testing

PKC inhibitors under study at Kyowa Hakko

Advanced Medicine claims novel antibiotic compounds

New nonpeptide glucagon antagonists useful for hyperglycemia, etc.

Abbott discovers novel nonpeptidic antagonists of LFA-1/ICAM-1 interaction

Novel factor Xa inhibitors under development for thromboembolic disorders

AstraZeneca receives patent for new series of pyrimidine compounds

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...